Low-carbohydrate diets as strategies for improving glycemic control in diabetic patients

Fol­low­ing a world-first trans­plant ear­li­er this year, eGe­n­e­sis has raised $191 mil­lion to con­tin­ue de­vel­op­ing ge­net­i­cal­ly mod­i­fied pig or­gans for peo­ple in dire need of

ANS-858 is an investigational selective and reversible ALDH2 inhibitor, which has been reported to reduce craving and drug-seeking behaviour in preclinical studies. Image Credit: Axel